Article

Multifocal ablations are option for correcting presbyopia

Multifocal ablations have been gaining ground for the correction of presbyopia in the past year. Here at the University of Ottawa we have been studying this approach with the VISX STAR S4 excimer laser, with promising results as many patients are able to achieve excellent near and distance acuity.

Multifocal ablations have been gaining ground for the correction of presbyopia in the past year. Here at the University of Ottawa we have been studying this approach with the VISX STAR S4 excimer laser, with promising results as many patients are able to achieve excellent near and distance acuity.

With VISX's patented ablation profile we create near acuity at the center of the cornea, with a steepened zone, and then target the periphery for distance. One of the major strengths of this approach is that it is less invasive than other proposed approaches for correcting presbyopia, such as scleral expansion bands, IOLs, and accommodating lenses. Here's a technique where you correct a refractive error as well as possibly higher-order aberrations and also leave the patient with some near vision.

For both distance and near vision, we found vision improved significantly after multifocal treatment. At the 3-month mark, 100% of patients (six eyes) attained 20/25 distance acuity or better. When it came to uncorrected near acuity, 100% were able to read J3 (20/40) or better, and 83% could see J1 (20/25) or better.

With this technique, at 3 months simultaneous uncorrected distance vision of 20/25 and near vision of J2 was achieved in all cases. So, all of these patients attained good distance vision of about 20/25 and were also able to read newspaper print. Out of that group we have a number of patients who do not wear any glasses whatsoever.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.